Newmont Corporation (NEM) compounding analysis
Full-size annual and quarterly year-over-year growth charts for revenue, EPS, operating cash flow, EBITDA, and free cash flow against the 15%, 20%, and 30% bars over 3-, 5-, and 10-year windows, with each metric's valuation multiple vs its own history.
Revenue · 10YDoes not currently clear the 15%+, 20%+, or 30%+ revenue bars over 10Y.
- Score
- 20/100
- 10Y CAGR
- 13.8%
- Median YoY
- 6.6%
- YoY volatility
- σ 25.4pp· choppy
- Quarters ≥ 20%
- 13 of 40
- Negative quarters
- 15
- Valuation vs own 10Y history
- P/S 5.9x · 10Y median 3.1x · 99th percentile · as of Aug 19, 2026
How this score is computed
- Quarters at or above 20%: 13 of 40 → 13 of 40 pts
- Steadiness (typical swing 25.4pp) → 6.9 of 25 pts
- Pace (median 6.6% YoY) → 0 of 20 pts
- Latest quarter (-34.5% YoY) → 0 of 15 pts
- Score: 20 of 100
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
Across metrics · 10Y
| Metric | 10Y CAGR | Median YoY | YoY σ | Qtrs ≥ 20% | Neg. qtrs |
|---|---|---|---|---|---|
| RevenueRevenue | 13.8% | 6.6% | 25.4pp | 13 of 40 | 15 |
| EPSEPS | 31.1% | 4.6% | 3554.0pp | 14 of 30 | 15 |
| Op cash flowOperating cash flow | 17% | 20.6% | 73.7pp | 20 of 40 | 17 |
| EBITDAEBITDA | 21.6% | 17.1% | 46.1pp | 19 of 40 | 13 |
| FCFFree cash flow | 25.6% | 29.1% | 287.4pp | 17 of 31 | 13 |
Reported figures over 10Y: annual-series CAGR, median and standard deviation (σ, percentage points) of quarterly year-over-year growth, quarters at or above 20%, and quarters with negative YoY. “—” means the window needs more comparable data.
Scores, qualification bars, and the 0–100 consistency methodology are documented on the compounders list page →
See also: NEM on the compounders surface · All compounders, ranked